Vitamin D seems to be an important factor for protecting from COVID-19 and treating patients that are ill with this virus. In brief, active vitamin D (calcitriol) has antiviral activity (e.g., via increasing synthesis of cathelicidin), modulates the immune system and has anti-inflammatory effects (and also damping the "cytokine storm").

Unfortunately, there is no official guidelines that could help the clinicians (particularly, family physicians) in dosing vitamin D for their patients, if the goal is to prevent the COVID-19 infection or at least to prevent heavy clinical forms and complications of that infection (like SARS or sepsis).

Some authors suggest that, for the aforementioned purpose, the 25-hydroxy-vitamin D levels should be at least 40 mg/ml. Therefore, the daily dose ~2000 IU that is recommended for the middle-age adults and ~4000 IU for low vitamin D risk group (the elderly, obese/overweight, those with malabsorption syndromes etc.) are too low. And also there is another problem: for many out-patients at present there is no possibility to perform 25-hydroxy-vitamin D analysis, due to well known reason (many patients should stay at home and avoid visits to out-patient clinics and laboratories, in order to avoid being infected with COVID-19).

So, what should You advise - what could be the starting dose? I guess we should recommend at least 4000 IU for generally healthy adults, and 8000 IU - for low vitamin D risk group (the elderly, obese/overweight, those with malabsorption syndromes etc.) per day. And after 8 weeks the analysis of 25-hydroxy-vitamin D levels should be performed, if possible.

Or maybe we should recommend much higher doses?

Similar questions and discussions